IsoRx Inc. is a leading provider of compounded radiopharmaceuticals, offering a comprehensive range of services in the San Francisco Bay Area, West Texas, and Guadalajara, Mexico. With a strong commitment to quality, IsoRx ensures compliance with industry standards and employs rigorous testing procedures to deliver sterile and pyrogen-free products.
Since its establishment in 1996, IsoRx has been at the forefront of innovation in the field, pioneering various projects such as micro-encapsulating compounded radioiodine for thyroid therapy and introducing the first independent radiopharmacy in California. With a focus on intelligent molecular imaging solutions, IsoRx continues to bring cutting-edge technology to the regions it serves.
Generated from the website